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Introduction 
Cystic fibrosis (CF) is an inherited disease. 
Although, in general a multiorgan disease, the res- 
piratory disorders cause considerable morbidity and 
nearly all of the mortality in patients with CF. 
Recently, lung transplantation became a viable 
option for those CF patients with end-stage lung 
disease and short life-expectancy (1,2). 
Case Report 
A 30-year-old male with CF was accepted for 
bilateral lung transplantation at St. Antonius 
Hospital, Nieuwegein, The Netherlands. Previously, 
he had a complicated pneumothorax on both sides, 
gastrointestinal problems, diabetes mellitus, pul- 
monary infections, and colonization with Aspergillus 
jiumigatus without evidence of allergic broncho- 
pulmonary aspergillosis. Post-operative, several 
complications occurred: three periods of rejection, 
an inappropriate reaction to immunosuppressive, 
infections (by several Pseudomonas species and 
cytomegalo-virus), nutritional and neurological 
problems. However, the major complication was a 
disseminated infection with A. jiumigatus located in 
the skin, brains, ears and lungs. This diagnosis was 
established by specimen cultures, serological methods 
to detect antibodies to A. fumigatus (precipitins, 
RAST and immunoblot-patterns in time). Antibiotic 
treatment was performed by tobramycin, ceftazi- 
dime, ciprofloxacine, aciclovir, ganciclovir, as well as 
empiric treatment by amphotericin B (0.5 mg kg - ’ 
day ~ ‘) and flucytosine. Immunosuppression therapy 
included cyclosporine, azathioprine, methyl- 
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prednisolon, anti-human thymocytes globulin and 
anti-human lymphocytes immune globulin. 
Sixty-two days post-operative, the first clinical 
demonstration of invasive aspergillus (i.e. epilepsy), 
became manifest in this patient. Three months after 
transplantation, the patient died due to haemoptoe. 
Pathological Findings 
Post-mortem examination demonstrated signs of 
bronchitis, bronchiolitis obliterans, pulmonary 
aspergillosis and Adult Respiratory Distress Syn- 
drome. A fistula between the bronchus of the right 
middle lobe and the pulmonary artery due to an 
invasive aspergillosis was the cause of the lethal 
bleeding (Plate 1). In addition, an invasive aspergillo- 
sis infection of the brain was demonstrated by a local 
lesion in the right occipital lobe, with involvement of 
the vessels with a diameter of 2.5 cm. 
Discussion 
A change towards more aggressive treatment in CF 
patients has lengthened their life-expectancy and 
many patients survive into adolescence. In accor- 
dance, lung transplantation has become one of the 
tools in the therapeutic regimen. However, shortage 
of suitable donor organs requires careful selection of 
recipients who would benefit from transplantation. 
Therefore, individual prognosis, quality of life and 
degree of disability must be evaluated both for sur- 
gical and post-operative management (1,2). Invasive 
disseminated aspergillosis is one of the most devas- 
tating opportunistic infections, which usually occurs 
in immunocompromised patients (3). Furthermore, 
diabetes mellitus -which occurs in about 15% of CF 
patients ~ predisposes to many infections. Aspergillus 
infections occur in 2-8% of patients with solid organ 
transplants (4). However, in lung transplantation 
patients, aspergillosis is often under-diagnosed since 
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Plate 1 Bronchial structure (B) and adjacent pulmonary artery (PA). Accumulation of A. fumigatus on the bronchial 
mucosal surface and invasion of the bronchial wall causing a fistula (*) between the bronchus of the right middle lobe and 
pulmonary artery. 
the underlying disease itself may be associated with 
similar symptoms (4,5). For those with disseminated 
disease and invasion of the central nervous system, 
outcome has mostly been fatal (4-7). Cerebral inva- 
sion by haematogenous dissemination may result in a 
variety of neurological signs. Cerebral aspergillosis 
should be strongly suspected in patients who develop 
pulmonary infiltrates and focal neurological signs, 
especially if they have received high dose steroids 
(6,7). Boon et al. (6) found invasive cerebral 
aspergillosis in 20% (n=9) of the patients who died 
after liver transplantation. In only two of these cases, 
the diagnosis was established before death. A biopsy 
specimen of an unusual rash may be the only means 
of establishing an early diagnosis of a disseminated 
fungal infection and is worthy of consideration. 
Therefore, the dermatological manifestations of 
systemic aspergillosis should not be overlooked. 
The case described above illustrates a dissemi- 
nated manifestation of infection with A. jiimigatus 
after bilateral lung transplantation. Predisposing 
factors - such as prolonged survival through inten- 
sive supportive treatment, rejection episodes with, as 
a consequence, an increase of immunosuppression, 
which predispose for infections, diabetes mellitus, 
and high dose corticosteroids - may have given the 
organism an opportunity to disseminate more widely 
(2,8). Before transplantation, colonization with A. 
fumigatus in the lung alone was documented in this 
patient. Seven days after transplantation, cultures of 
wound, cerumen and drains, as well, became positive 
for A. jiimigatus. Therefore, we suggest that colon- 
ization before operation predisposes for invasive 
aspergillosis and treatment should be considered. 
Despite antifungal treatment, the CF patient 
described died due to invasion of A. jiimigatus. With 
regard to aspergillosis, the prognosis of survival 
after lung transplantation in CF depends on (pre- 
operative) clinical presentation and pre-operative 
screening (using well-defined criteria) for coloniz- 
ation of the entire respiratory tract, with high 
attention for the diverse manifestations of dissemi- 
nated aspergillosis. 
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